vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and UiPath, Inc. (PATH). Click either name above to swap in a different company.

UiPath, Inc. is the larger business by last-quarter revenue ($411.1M vs $379.6M, roughly 1.1× DIVERSIFIED HEALTHCARE TRUST). UiPath, Inc. runs the higher net margin — 48.4% vs -5.6%, a 54.0% gap on every dollar of revenue. On growth, UiPath, Inc. posted the faster year-over-year revenue change (15.9% vs -0.0%). UiPath, Inc. produced more free cash flow last quarter ($25.1M vs $-166.4M). Over the past eight quarters, DIVERSIFIED HEALTHCARE TRUST's revenue compounded faster (1.2% CAGR vs 0.7%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

UiPath Inc. is a global software company that develops artificial intelligence (AI) and agentic automation and orchestration software. The company's software enables the building and orchestration of AI agents to automate complex processes and workflows.

DHC vs PATH — Head-to-Head

Bigger by revenue
PATH
PATH
1.1× larger
PATH
$411.1M
$379.6M
DHC
Growing faster (revenue YoY)
PATH
PATH
+15.9% gap
PATH
15.9%
-0.0%
DHC
Higher net margin
PATH
PATH
54.0% more per $
PATH
48.4%
-5.6%
DHC
More free cash flow
PATH
PATH
$191.5M more FCF
PATH
$25.1M
$-166.4M
DHC
Faster 2-yr revenue CAGR
DHC
DHC
Annualised
DHC
1.2%
0.7%
PATH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
DHC
DHC
PATH
PATH
Revenue
$379.6M
$411.1M
Net Profit
$-21.2M
$198.8M
Gross Margin
83.3%
Operating Margin
-12.6%
3.2%
Net Margin
-5.6%
48.4%
Revenue YoY
-0.0%
15.9%
Net Profit YoY
75.7%
1966.2%
EPS (diluted)
$-0.09
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
PATH
PATH
Q4 25
$379.6M
$411.1M
Q3 25
$388.7M
$361.7M
Q2 25
$382.7M
$356.6M
Q1 25
$386.9M
$423.6M
Q4 24
$379.6M
$354.7M
Q3 24
$373.6M
$316.3M
Q2 24
$371.4M
$335.1M
Q1 24
$370.8M
$405.3M
Net Profit
DHC
DHC
PATH
PATH
Q4 25
$-21.2M
$198.8M
Q3 25
$-164.0M
$1.6M
Q2 25
$-91.6M
$-22.6M
Q1 25
$-9.0M
$51.8M
Q4 24
$-87.4M
$-10.7M
Q3 24
$-98.7M
$-86.1M
Q2 24
$-97.9M
$-28.7M
Q1 24
$-86.3M
$33.9M
Gross Margin
DHC
DHC
PATH
PATH
Q4 25
83.3%
Q3 25
82.2%
Q2 25
82.1%
Q1 25
84.8%
Q4 24
82.0%
Q3 24
80.0%
Q2 24
83.5%
Q1 24
86.8%
Operating Margin
DHC
DHC
PATH
PATH
Q4 25
-12.6%
3.2%
Q3 25
-43.4%
-5.6%
Q2 25
-24.5%
-4.6%
Q1 25
-2.7%
7.9%
Q4 24
-26.1%
-12.2%
Q3 24
-26.5%
-32.7%
Q2 24
-23.0%
-14.8%
Q1 24
-23.7%
3.7%
Net Margin
DHC
DHC
PATH
PATH
Q4 25
-5.6%
48.4%
Q3 25
-42.2%
0.4%
Q2 25
-23.9%
-6.3%
Q1 25
-2.3%
12.2%
Q4 24
-23.0%
-3.0%
Q3 24
-26.4%
-27.2%
Q2 24
-26.3%
-8.6%
Q1 24
-23.3%
8.4%
EPS (diluted)
DHC
DHC
PATH
PATH
Q4 25
$-0.09
$0.37
Q3 25
$-0.68
$0.00
Q2 25
$-0.38
$-0.04
Q1 25
$-0.04
$0.09
Q4 24
$-0.37
$-0.02
Q3 24
$-0.41
$-0.15
Q2 24
$-0.41
$-0.05
Q1 24
$-0.36
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
PATH
PATH
Cash + ST InvestmentsLiquidity on hand
$105.4M
$1.4B
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$1.7B
$1.9B
Total Assets
$4.4B
$2.9B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
PATH
PATH
Q4 25
$105.4M
$1.4B
Q3 25
$201.4M
$1.4B
Q2 25
$141.8M
$1.6B
Q1 25
$302.6M
$1.6B
Q4 24
$144.6M
$1.6B
Q3 24
$256.5M
$1.7B
Q2 24
$265.6M
$1.9B
Q1 24
$207.1M
$1.9B
Total Debt
DHC
DHC
PATH
PATH
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
PATH
PATH
Q4 25
$1.7B
$1.9B
Q3 25
$1.7B
$1.7B
Q2 25
$1.9B
$1.7B
Q1 25
$1.9B
$1.8B
Q4 24
$2.0B
$1.7B
Q3 24
$2.0B
$1.8B
Q2 24
$2.1B
$2.0B
Q1 24
$2.2B
$2.0B
Total Assets
DHC
DHC
PATH
PATH
Q4 25
$4.4B
$2.9B
Q3 25
$4.7B
$2.6B
Q2 25
$4.8B
$2.6B
Q1 25
$5.0B
$2.9B
Q4 24
$5.1B
$2.7B
Q3 24
$5.3B
$2.7B
Q2 24
$5.3B
$2.8B
Q1 24
$5.3B
$3.0B
Debt / Equity
DHC
DHC
PATH
PATH
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
PATH
PATH
Operating Cash FlowLast quarter
$-19.6M
$28.3M
Free Cash FlowOCF − Capex
$-166.4M
$25.1M
FCF MarginFCF / Revenue
-43.8%
6.1%
Capex IntensityCapex / Revenue
38.7%
0.8%
Cash ConversionOCF / Net Profit
0.14×
TTM Free Cash FlowTrailing 4 quarters
$-280.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
PATH
PATH
Q4 25
$-19.6M
$28.3M
Q3 25
$-49.3M
$41.6M
Q2 25
$53.0M
$119.0M
Q1 25
$-3.2M
$146.1M
Q4 24
$112.2M
$28.1M
Q3 24
$21.1M
$46.4M
Q2 24
$44.3M
$100.0M
Q1 24
$28.6M
$145.6M
Free Cash Flow
DHC
DHC
PATH
PATH
Q4 25
$-166.4M
$25.1M
Q3 25
$-89.8M
Q2 25
$18.8M
$106.2M
Q1 25
$-42.9M
$138.7M
Q4 24
$-89.5M
$23.2M
Q3 24
$-26.1M
$45.0M
Q2 24
$3.3M
$98.8M
Q1 24
$-18.1M
$141.8M
FCF Margin
DHC
DHC
PATH
PATH
Q4 25
-43.8%
6.1%
Q3 25
-23.1%
Q2 25
4.9%
29.8%
Q1 25
-11.1%
32.7%
Q4 24
-23.6%
6.5%
Q3 24
-7.0%
14.2%
Q2 24
0.9%
29.5%
Q1 24
-4.9%
35.0%
Capex Intensity
DHC
DHC
PATH
PATH
Q4 25
38.7%
0.8%
Q3 25
10.4%
0.0%
Q2 25
8.9%
3.6%
Q1 25
10.2%
1.7%
Q4 24
53.1%
1.4%
Q3 24
12.6%
0.4%
Q2 24
11.0%
0.4%
Q1 24
12.6%
0.9%
Cash Conversion
DHC
DHC
PATH
PATH
Q4 25
0.14×
Q3 25
26.25×
Q2 25
Q1 25
2.82×
Q4 24
Q3 24
Q2 24
Q1 24
4.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

Related Comparisons